SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-353939
Filing Date
2021-12-10
Accepted
2021-12-10 16:07:54
Documents
16
Period of Report
2021-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d260712d8k.htm   iXBRL 8-K 29591
2 EX-1.1 d260712dex11.htm EX-1.1 182335
3 EX-5.1 d260712dex51.htm EX-5.1 13142
7 GRAPHIC g260712g1209112221818.jpg GRAPHIC 2345
8 GRAPHIC g260712latham_logo2.jpg GRAPHIC 3220
  Complete submission text file 0001193125-21-353939.txt   415617

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA freq-20211210.xsd EX-101.SCH 2889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20211210_lab.xml EX-101.LAB 18888
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20211210_pre.xml EX-101.PRE 11858
9 EXTRACTED XBRL INSTANCE DOCUMENT d260712d8k_htm.xml XML 3478
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 211485350
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences